Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,799,729
+$1,487,196 QoQ
Shares Held
7,152
+397.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#2,047
of 4,153 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cullen Capital Management, LLC holds $1,067,869,600 across 8 Drug Manufacturers - General names. ABBV ranks #8 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVS |
Novartis AG
|
2,033,040 | $318,618,028 | |
| 2 | JNJ |
Johnson & Johnson
|
1,099,077 | $279,132,585 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,016,795 | $259,158,157 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
1,132,367 | $65,246,986 | |
| 5 | PFE |
Pfizer Inc
|
2,447,200 | $58,928,576 | |
| 6 | NVO |
Novo Nordisk A S
|
1,224,955 | $58,724,342 | |
| 7 | SNY |
Sanofi
|
615,593 | $26,261,197 | |
| 8 | ABBV |
AbbVie Inc.
This page
|
7,152 | $1,799,729 |
All Filings in ABBV
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,799,729 | 7,152 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $312,533 | 1,437 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $456,294 | 1,997 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $288,730 | 1,247 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $231,468 | 1,247 | Shares | Sole | 2025-09-30 | |
| 2025-03-31 | $490,695 | 2,342 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $670,284 | 3,772 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $744,894 | 3,772 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $646,973 | 3,772 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $686,881 | 3,772 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $538,365 | 3,474 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $482,954 | 3,240 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $462,393 | 3,432 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $546,957 | 3,432 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $568,867 | 3,520 | Shares | Sole | 2023-02-16 | |
| 2022-09-30 | $472,419 | 3,520 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $496,238 | 3,240 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $525,236 | 3,240 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $488,658 | 3,609 | Shares | Sole | 2022-02-10 | |
| 2021-06-30 | $397,056 | 3,525 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $380,501 | 3,516 | Shares | Sole | 2021-05-10 | |
| No filing history on record for this holder in this stock. | ||||||